149 related articles for article (PubMed ID: 33445752)
1. Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A.
Azamor T; da Silva AMV; Melgaço JG; Dos Santos AP; Xavier-Carvalho C; Alvarado-Arnez LE; Batista-Silva LR; de Souza Matos DC; Bayma C; Missailidis S; Ano Bom APD; Moraes MO; da Costa Neves PC
Viruses; 2021 Jan; 13(1):. PubMed ID: 33445752
[TBL] [Abstract][Full Text] [Related]
2. Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses.
Neves PC; Santos JR; Tubarão LN; Bonaldo MC; Galler R
PLoS One; 2013; 8(12):e81953. PubMed ID: 24324734
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.
Kongsgaard M; Bassi MR; Rasmussen M; Skjødt K; Thybo S; Gabriel M; Hansen MB; Christensen JP; Thomsen AR; Buus S; Stryhn A
Sci Rep; 2017 Apr; 7(1):662. PubMed ID: 28386132
[TBL] [Abstract][Full Text] [Related]
4. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
[TBL] [Abstract][Full Text] [Related]
5. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
6. Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Campi-Azevedo AC; Costa-Pereira C; Antonelli LR; Fonseca CT; Teixeira-Carvalho A; Villela-Rezende G; Santos RA; Batista MA; Campos FM; Pacheco-Porto L; Melo Júnior OA; Hossell DM; Coelho-dos-Reis JG; Peruhype-Magalhães V; Costa-Silva MF; de Oliveira JG; Farias RH; Noronha TG; Lemos JA; von Doellinger Vdos R; Simões M; de Souza MM; Malaquias LC; Persi HR; Pereira JM; Martins JA; Dornelas-Ribeiro M; Vinhas Ade A; Alves TR; Maia Mde L; Freire Mda S; Martins Rde M; Homma A; Romano AP; Domingues CM; Tauil PL; Vasconcelos PF; Rios M; Caldas IR; Camacho LA; Martins-Filho OA
Hum Vaccin Immunother; 2016; 12(2):491-502. PubMed ID: 26360663
[TBL] [Abstract][Full Text] [Related]
7. Association of rs1285933 single nucleotide polymorphism in CLEC5A gene with dengue severity and its functional effects.
Xavier-Carvalho C; Cezar RDDS; Freire NM; Vasconcelos CMM; Solorzano VEF; de Toledo-Pinto TG; Fialho LG; do Carmo RF; Vasconcelos LRS; Cordeiro MT; Baptista P; de Azeredo EL; da Cunha RV; de Souza LJ; Pacheco AG; Kubelka CF; Moura PMMF; Moraes MO
Hum Immunol; 2017 Oct; 78(10):649-656. PubMed ID: 28764923
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.
Colin de Verdiere N; Durier C; Samri A; Meiffredy V; Launay O; Matheron S; Mercier-Delarue S; Even S; Aboulker JP; Molina JM; Autran B; Simon F;
AIDS; 2018 Oct; 32(16):2291-2299. PubMed ID: 30096071
[TBL] [Abstract][Full Text] [Related]
9. A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.
Hou J; Wang S; Jia M; Li D; Liu Y; Li Z; Zhu H; Xu H; Sun M; Lu L; Zhou Z; Peng H; Zhang Q; Fu S; Liang G; Yao L; Yu X; Carpp LN; Huang Y; McElrath J; Self S; Shao Y
J Immunol; 2017 Aug; 199(4):1476-1489. PubMed ID: 28687661
[TBL] [Abstract][Full Text] [Related]
10. CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses.
Neves PC; Rudersdorf RA; Galler R; Bonaldo MC; de Santana MG; Mudd PA; Martins MA; Rakasz EG; Wilson NA; Watkins DI
Vaccine; 2010 Nov; 28(51):8183-8. PubMed ID: 20939995
[TBL] [Abstract][Full Text] [Related]
11. Duration of post-vaccination humoral immunity against yellow fever in children.
de Noronha TG; de Lourdes de Sousa Maia M; Geraldo Leite Ribeiro J; Campos Lemos JA; Maria Barbosa de Lima S; Martins-Filho OA; Campi-Azevedo AC; da Silva Freire M; de Menezes Martins R; Bastos Camacho LA;
Vaccine; 2019 Nov; 37(48):7147-7154. PubMed ID: 31590934
[TBL] [Abstract][Full Text] [Related]
12. The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.
Watson AM; Lam LK; Klimstra WB; Ryman KD
PLoS Pathog; 2016 Jul; 12(7):e1005786. PubMed ID: 27463517
[TBL] [Abstract][Full Text] [Related]
13. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB
J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797
[TBL] [Abstract][Full Text] [Related]
14. Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
Collaborative group for studies on yellow fever vaccines
Vaccine; 2019 Aug; 37(35):5129-5135. PubMed ID: 31171393
[TBL] [Abstract][Full Text] [Related]
15. TLR expression and NK cell activation after human yellow fever vaccination.
Neves PC; Matos DC; Marcovistz R; Galler R
Vaccine; 2009 Sep; 27(41):5543-9. PubMed ID: 19647065
[TBL] [Abstract][Full Text] [Related]
16. Genetic association analysis of
Elleisy N; Rohde S; Huth A; Gittel N; Glass Ä; Möller S; Lamprecht G; Schäffler H; Jaster R
World J Gastroenterol; 2020 May; 26(18):2194-2202. PubMed ID: 32476786
[TBL] [Abstract][Full Text] [Related]
17. CLEC5A is a critical receptor in innate immunity against Listeria infection.
Chen ST; Li FJ; Hsu TY; Liang SM; Yeh YC; Liao WY; Chou TY; Chen NJ; Hsiao M; Yang WB; Hsieh SL
Nat Commun; 2017 Aug; 8(1):299. PubMed ID: 28824166
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
[TBL] [Abstract][Full Text] [Related]
19. The early cellular signatures of protective immunity induced by live viral vaccination.
Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
Roukens AHE; van Halem K; de Visser AW; Visser LG
Ann Intern Med; 2018 Dec; 169(11):761-765. PubMed ID: 30476963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
